Clinical Aspects of Pregnancy and Delivery in Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP) .
10.3904/kjim.2005.20.2.129
- Author:
Young Woong WON
1
;
Won MOON
;
Yeong Seop YUN
;
Ho Suk OH
;
Jung Hye CHOI
;
Young Yeul LEE
;
In Soon KIM
;
Il Young CHOI
;
Myung Ju AHN
Author Information
1. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. ahnmj@hanyang.ac.kr
- Publication Type:Original Article ; Comparative Study
- Keywords:
Purpura;
Thrombocytopenic;
Idiopathic;
Pregnancy;
Delivery;
Obstetric
- MeSH:
Adult;
Chronic Disease;
Comparative Study;
*Delivery, Obstetric/methods;
Female;
Glucocorticoids/therapeutic use;
Humans;
Immunoglobulin G/administration & dosage/therapeutic use;
Immunoglobulins, Intravenous/therapeutic use;
Infant, Newborn;
Platelet Count;
Platelet Transfusion;
Pregnancy;
*Pregnancy Complications, Hematologic/blood/diagnosis;
*Pregnancy Outcome;
*Purpura, Thrombocytopenic, Idiopathic/blood/diagnosis/therapy;
Retrospective Studies
- From:The Korean Journal of Internal Medicine
2005;20(2):129-134
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) is a condition that often develops in young women and, consequently, physicians should frequently manage and monitor pregnant patients with this disorder. METHODS: We reviewed the charts of 30 women with chronic ITP delivered in 31 pregnancies from January 1995 to December 2003. RESULTS: Fifteen patients were diagnosed with ITP before pregnancy and sixteen patients were diagnosed during pregnancy. The mean platelet counts before pregnancy, during pregnancy, and at delivery were 70, 040/mm3, 83, 960/mm3, and 62, 680/mm3, respectively. The symptoms of hemostatic impairment were not noted in most of the pregnancies (77%, 24/31). During pregnancy and at delivery, most of the women (61%, 19/31) received various kinds of treatment to raise platelet counts. At delivery, the most commonly used therapy was platelet transfusion (48.4%, 15/31). Seven pregnancies (22.6%) were treated with corticosteroids during pregnancy and at delivery. Five pregnancies (16.1%) were treated with IV IgG during pregnancy and at delivery. Fifteen deliveries (51.7%) were performed by cesarean section and fourteen (48.3%) with vaginal delivery. Bleeding was uncommon at delivery. There were no cases of infants with any clinical signs of hemorrhage. CONCLUSION: Our current results suggest that ITP in pregnancy can proceed safely with low hemorrhagic risk in both infants and mothers, and that mothers with ITP can deliver healthy infants without serious hemorrhagic complications.
